Wyniki wyszukiwania dla: INVERSE AGONIST

• INVERSE PROBLEMS

  Czasopisma

  ISSN: 0266-5611 , eISSN: 1361-6420

• Inverse Problems and Imaging

  Czasopisma

  ISSN: 1930-8337 , eISSN: 1930-8345

• The Monist

  Czasopisma

  ISSN: 0026-9662 , eISSN: 2153-3601

• Protecting Wireless Mesh Networks Against Adverse Weather Conditions

  Publikacja

  • E. Fitzgerald
  • M. Pioro
  • A. Tomaszewski

  - Rok 2018

  Pełny tekst do pobrania w serwisie zewnętrznym

• Inverse shadowing and related measures

  Publikacja

  • S. Kryzhevich
  • S. Pilyugin

  - Science China-Mathematics - Rok 2020

  We study various weaker forms of the inverse shadowing property for discrete dynamical systems on a smooth compact manifold. First, we introduce the so-called ergodic inverse shadowing property (Birkhoff averages of continuous functions along an exact trajectory and the approximating one are close). We demonstrate that this property implies the continuity of the set of invariant measures in the Hausdorff metric. We show that the...

  Pełny tekst do pobrania w portalu

• INVERSE PROBLEMS IN SCIENCE AND ENGINEERING

  Czasopisma

  ISSN: 1741-5977 , eISSN: 1741-5985

• Inverse Potassium Hydride:  A Theoretical Study

  Publikacja

  • A. Sawicka
  • P. Skurski
  • J. Simons

  - JOURNAL OF PHYSICAL CHEMISTRY A - Rok 2005

  Pełny tekst do pobrania w serwisie zewnętrznym

• Inverse Sodium Hydride:  A Theoretical Study

  Publikacja

  • A. Sawicka
  • P. Skurski
  • J. Simons

  - JOURNAL OF THE AMERICAN CHEMICAL SOCIETY - Rok 2003

  Pełny tekst do pobrania w serwisie zewnętrznym

• (4-(Bis(4-Fluorophenyl)Methyl)Piperazin-1-yl)(Cyclohexyl)Methanone Hydrochloride (LDK1229): A New Cannabinoid CB1 Receptor Inverse Agonist from the Class of Benzhydryl Piperazine Analogs

  Publikacja

  • M. M. Mahmoud
  • T. Olszewska
  • H. Liu
  • D. M. Shore
  • D. P. Hurst
  • P. H. Reggio
  • D. Lu
  • D. A. Kendall

  - MOLECULAR PHARMACOLOGY - Rok 2015

  Some inverse agonists of cannabinoid receptor type 1 (CB1) have been demonstrated to be anorectic antiobesity drug candidates. However, the first generation of CB1 inverse agonists, represented by rimonabant (SR141716A), otenabant, and taranabant, are centrally active, with a high level of psychiatric side effects. Hence, the discovery of CB1 inverse agonists with a chemical scaffold distinct from these holds promise for developing...

  Pełny tekst do pobrania w serwisie zewnętrznym

• Universe-Taipei

  Czasopisma

  ISSN: 2309-852X